SciTransfer
Organization

COSMETICS EUROPE - THE PERSONAL CARE ASSOCIATION

European cosmetics industry association driving regulatory acceptance of next-generation, animal-free toxicology and risk assessment methods.

NGO / AssociationhealthBE
H2020 projects
2
As coordinator
0
Total EC funding
Unique partners
58
What they do

Their core work

Cosmetics Europe is the European trade association representing manufacturers and distributors of cosmetics and personal care products. In EU research, they act as the industry voice in large toxicology consortia, ensuring that next-generation safety testing methods are both scientifically credible and practically applicable to real formulation and ingredient challenges. Their core contribution is bridging academic research on mechanism-based toxicology with the regulatory and commercial realities of the personal care sector. They are particularly valuable for driving regulatory acceptance of new approach methodologies (NAMs) — a strategic priority for the entire industry given the EU's long-standing ban on animal testing in cosmetics.

Core expertise

What they specialise in

2 projects

Both EU-ToxRisk and RISK-HUNT3R directly target NGRA frameworks, with RISK-HUNT3R explicitly focused on 'next generation testing strategies' and their regulatory acceptance.

Adverse Outcome Pathways (AOPs) and Systems Toxicologyprimary
2 projects

AOPs, systems toxicology, and molecular mechanisms are core keywords in EU-ToxRisk; quantitative AOP networks and toxicodynamics extend this work in RISK-HUNT3R.

Toxicokinetics and Exposure Modellingemerging
1 project

RISK-HUNT3R introduces exposure modelling and toxicokinetics as newer capability layers built on top of the mechanistic toxicology foundation established in EU-ToxRisk.

Industry-Regulatory Interface for Chemical Safetysecondary
2 projects

As a trade association in both projects, Cosmetics Europe ensures research outputs address real formulation constraints and practical regulatory acceptance pathways for personal care products.

Evolution & trajectory

How they've shifted over time

Early focus
Mechanism-based toxicity modelling
Recent focus
Regulatory acceptance of next-gen testing

In EU-ToxRisk (2016–2021), the focus was on building scientific infrastructure: AOPs, systems toxicology, cheminformatics, and mechanistic models for repeated dose and developmental toxicity. In RISK-HUNT3R (2021–2026), the emphasis shifted decisively toward applying and validating those methods — exposure modelling, toxicokinetics, real-world case studies, and regulatory acceptance. The trajectory is a deliberate move from scientific proof-of-concept to real-world implementation and uptake by regulators and industry practitioners.

They are moving from developing new toxicology tools to ensuring those tools are accepted by regulators and adopted across the industry, making them increasingly valuable for any consortium aiming to translate NAMs into approved safety workflows.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European14 countries collaborated

Cosmetics Europe consistently joins as a participant rather than leading projects, contributing industry expertise and end-user perspective to large academic-led consortia. With 58 unique partners across 14 countries from just 2 projects, they are embedded in very large flagship networks — not small, tight-knit collaborations. Their role is to represent a key industrial sector's needs, validate research outputs against real-world use cases, and open doors to regulatory acceptance.

Despite only 2 projects, Cosmetics Europe has built a network of 58 unique partners spanning 14 countries — reflecting the large-scale European flagship programs they participate in. Their network is European in reach, centered on toxicology research institutes, universities, and chemical industry players.

Why partner with them

What sets them apart

As the authoritative voice of the European cosmetics industry in EU research, Cosmetics Europe brings something no academic or SME partner can replicate: direct access to industry testing needs, sector-wide regulatory intelligence, and the ability to mobilize industry-wide adoption of new methods. For any consortium working on alternative testing methods or chemical safety, having this association as a partner signals industry relevance and materially increases the likelihood of regulatory uptake. They also carry institutional continuity across multiple research generations — their involvement in both EU-ToxRisk and RISK-HUNT3R shows they are a sustained, strategic actor rather than an opportunistic participant.

Notable projects

Highlights from their portfolio

  • EU-ToxRisk
    A major European flagship program on mechanism-based toxicity testing that laid the scientific foundation for animal-free safety assessment — Cosmetics Europe's involvement reflects the industry's strategic commitment to developing alternatives to animal testing at a formative stage.
  • RISK-HUNT3R
    The follow-on program (2021–2026) that takes NGRA from science to practice with an explicit focus on regulatory acceptance, representing the most advanced current effort to operationalize next-generation toxicology for real industry use.
Cross-sector capabilities
Chemical industry safety and regulatory compliancePharmaceutical toxicology and alternative non-animal testing methodsFood safety — exposure modelling and risk assessment frameworksEnvironmental health — AOP network methodologies applicable beyond personal care
Analysis note: Only 2 projects available, limiting analytical depth. Both projects are thematically coherent and large-scale, allowing reliable expertise mapping and evolution analysis. EC funding amounts are unavailable, so budget-based weighting could not be applied. Profile is reliable for expertise and role characterization but network depth claims should be treated as indicative rather than definitive.